Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF plus myocardial contrast echocardiography with sulphur hexafluoride in post-infarction left ventricular function
2015-002189-21Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- May 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lenograstim and sulfur hexafluoride in myocardial infarction (MI), sponsored by Policlinico Gemelli. Primary endpoint: Improvement in post-infarction left ventricular function. Started May 2021; status: completed.
02
Drugs
lenograstimsulfur hexafluoride
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2015-002189-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002189-21.